Next Steps to Treat Parkinson’s, Huntington’s and Alzheimer’s Disease

Hosted By: Helen Winsor
Rate this Podcast: 
Be the first!
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

About this Podcast...

Joachim Tedroff, Head of Clinical Science at NeuroSearch Sweden AB, joins Helen Winsor from Pharma IQ, to discuss strategies for optimising clinical development in CNS. First Tedroff outlines what he sees as the major challenges in the development of CNS therapies coming onto the market. In the second part of the interview, he provides an update on NeuroSearch’s recent success with a Phase III clinical trial for Huntington’s Disease patients. He elaborates on the work underway and discusses whether this might open up therapeutic opportunities within Alzheimer's disease.


Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018